肝移植患儿并发淋巴组织增生性疾病缓解后继发颅内 Burkitt 淋巴瘤一例

关键词

儿童 / 肝移植 / 移植后淋巴组织增生性疾病 / 大剂量甲氨蝶呤 / Burkitt 淋巴瘤

参考文献

[1] Llaurador G, McLaughlin L, Wistinghausen B . Management of post-transplant lymphoproliferative disorders[J]. Curr Opin Pediatr, 2017, 29(1): 34-40.

[2] Hsu CT, Chang MH, Ho MC, et al. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan[J]. J Formos Med Assoc, 2019, 118(11): 1537-1545.

[3] Liu Y, Sun LY, Zhu ZJ, et al. Post-transplant lymphoproliferative disorder after paediatric liver transplantation[J]. Int J Clin Pract, 2021, 75(4): e13843.

[4] Barış Z, Özçay F, Yılmaz Özbek Ö, et al. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy[J]. Turk J Gastroenterol, 2018, 29(3): 354-360.

[5] Baker A, Frauca Remacha E, Torres Canizales J, et al. Current practices on diagnosis, prevention and treatment of post-transplant lymphoproliferative disorder in pediatric patients after solid organ transplantation: results of ERN TransplantChild healthcare working group survey[J]. Children (Basel), 2021, 8(8): 661.

[6] Simakachorn L, Tanpowpong P, Lertudomphonwanit C, et al. Various initial presentations of Epstein-Barr virus infection-associated post-transplant lymphoproliferative disorder in pediatric liver transplantation recipients: case series and literature review[J]. Pediatr Transplant, 2019, 23(2): e13357.

[7] Opelz G, Döhler B, Ruhenstroth A . Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report[J]. Am J Transplant, 2004, 4(6): 928-936.

[8] Schneck SA, Penn I . Cerebral neoplasms associated with renal transplantation[J]. Arch Neurol, 1970, 22(3): 226-233.

[9] Cavaliere R, Petroni G, Lopes MB, et al. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report[J]. Cancer, 2010, 116(4): 863-870.

[10] Buell JF, Gross TG, Hanaway MJ, et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement[J]. Transplant Proc, 2005, 37(2): 954-955.

[11] Gregorek H, Jankowska I, Dzierzanowska-Fangrat K, et al. Long-term monitoring of Epstein-Barr virus DNA load and humoral parameter abnormalities in pediatric liver transplant recipients before development of malignancy[J]. Pediatr Transplant, 2010, 14(5): 629-635.

[12] Dierickx D, Habermann TM . Post-transplantation lymphoproliferative disorders in adults[J]. N Engl J Med, 2018, 378(6): 549-562.

[13] Trappe R, Oertel S, Leblond V, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial[J]. Lancet Oncol, 2012, 13(2): 196-206.

[14] Rubinstein JD, Shah R, Breese EH, et al. Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: short-course EPOCH regimens are safe and effective[J]. Pediatr Blood Cancer, 2021, 68(8): e29126.

[15] Wang T, Feng M, Luo C, et al. Successful treatment of pediatric refractory burkitt lymphoma PTLD after liver transplantation using anti-CD19 chimeric antigen receptor T-cell therapy[J]. Cell Transplant, 2021, 30: 963689721996649.

[16] Abramovich A, Adam E, Shapira A, et al. CD28-costimulated CD19 CAR-T cells for pediatric mature non-Hodgkin B-cell lymphoma[J]. Bone Marrow Transplant, 2025, 60(7): 1045-1051.